| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-11 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |